Patient‐reported outcomes and treatment adherence in type 2 diabetes using natural language processing: Wave 8 of the Observational International Diabetes Management Practices Study

Juliana CN Chan,Jean Claude Mbanya,Jean‐Marc Chantelot,Marina Shestakova,Ambady Ramachandran,Hasan Ilkova,Lucille Deplante,Melissa Rollot,Lydie Melas‐Melt,Juan Jose Gagliardino,Pablo Aschner
DOI: https://doi.org/10.1111/jdi.14228
2024-06-07
Journal of Diabetes Investigation
Abstract:Reasons for (a) non‐adherence and (b) adherence in patients with type 2 diabetes. Aims/Introduction We analyzed patient‐reported outcomes of people with type 2 diabetes to better understand perceptions and experiences contributing to treatment adherence. Materials and Methods In the ongoing International Diabetes Management Practices Study, we collected patient‐reported outcomes data from structured questionnaires (chronic treatment acceptance questionnaire and Diabetes Self‐Management Questionnaire) and free‐text answers to open‐ended questions to assess perceptions of treatment value and side‐effects, as well as barriers to, and enablers for, adherence and self‐management. Free‐text answers were analyzed by natural language processing. Results In 2018–2020, we recruited 2,475 patients with type 2 diabetes (43.3% insulin‐treated, glycated hemoglobin (HbA1c) 8.0 ± 1.8%; 30.9% with HbA1c <7%) from 13 countries across Africa, the Middle East, Europe, Latin America and Asia. Mean ± standard deviation scores of chronic treatment acceptance questionnaire (acceptance of medication, rated out of 100) and Diabetes Self‐Management Questionnaire (self‐management, rated out of 10) were 87.8 ± 24.5 and 3.3 ± 0.9, respectively. Based on free‐text analysis and coded responses, one in three patients reported treatment non‐adherence. Overall, although most patients accepted treatment values and side‐effects, self‐management was suboptimal. Treatment duration, regimen complexity and disruption of daily routines were major barriers to adherence, whereas habit formation was a key enabler. Treatment‐adherent patients were older (60 ± 11.6 vs 55 ± 11.7 years, P
endocrinology & metabolism
What problem does this paper attempt to address?